title: Somatosensory profiles but not numbers of somatosensory abnormalities of neuropathic pain patients correspond with neuropathic pain grading.
abstract: Due to the lack of a specific diagnostic tool for neuropathic pain, a grading system to categorize pain as 'definite', 'probable', 'possible' and 'unlikely' neuropathic was proposed. Somatosensory abnormalities are common in neuropathic pain and it has been suggested that a greater number of abnormalities would be present in patients with 'probable' and 'definite' grades. To test this hypothesis, we investigated the presence of somatosensory abnormalities by means of Quantitative Sensory Testing (QST) in patients with a clinical diagnosis of neuropathic pain and correlated the number of sensory abnormalities and sensory profiles to the different grades. Of patients who were clinically diagnosed with neuropathic pain, only 60% were graded as 'definite' or 'probable', while 40% were graded as 'possible' or 'unlikely' neuropathic pain. Apparently, there is a mismatch between a clinical neuropathic pain diagnosis and neuropathic pain grading. Contrary to the expectation, patients with 'probable' and 'definite' grades did not have a greater number of abnormalities. Instead, similar numbers of somatosensory abnormalities were identified for each grade. The profiles of sensory signs in 'definite' and 'probable' neuropathic pain were not significantly different, but different from the 'unlikely' grade. This latter difference could be attributed to differences in the prevalence of patients with a mixture of sensory gain and loss and with sensory loss only. The grading system allows a separation of neuropathic and non-neuropathic pain based on profiles but not on the total number of sensory abnormalities. Our findings indicate that patient selection based on grading of neuropathic pain may provide advantages in selecting homogenous groups for clinical research.
authors.affiliation: Department of Anesthesiology, Pain Management Unit, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. k.h.konopka@umcg.nl
authors.forename: Karl-Heinz
authors.initials: KH
authors.lastname: Konopka
authors.forename: Marten
authors.initials: M
authors.lastname: Harbers
authors.forename: Andrea
authors.initials: A
authors.lastname: Houghton
authors.forename: Rudie
authors.initials: R
authors.lastname: Kortekaas
authors.forename: Andre
authors.initials: A
authors.lastname: van Vliet
authors.forename: Wia
authors.initials: W
authors.lastname: Timmerman
authors.forename: Johan A
authors.initials: JA
authors.lastname: den Boer
authors.forename: Michel M R F
authors.initials: MM
authors.lastname: Struys
authors.forename: Marten
authors.initials: M
authors.lastname: van Wijhe
mesh_terms: D000328:Adult; D000368:Aged; D016022:Case-Control Studies; D015331:Cohort Studies; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009437:Neuralgia / Q000175:diagnosis* / Q000473:pathology*; D011984:Sensory Receptor Cells / Q000473:pathology*; D055815:Young Adult